See more : Guangdong Bobaolon Co.,Ltd. (002776.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Narayana Hrudayalaya Limited (NH.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Narayana Hrudayalaya Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- PT Malindo Feedmill Tbk (MAIN.JK) Income Statement Analysis – Financial Results
- Golden Energy Offshore Services AS (GEOUF) Income Statement Analysis – Financial Results
- Siyata Mobile Inc. (SYTA) Income Statement Analysis – Financial Results
- Fiducial Real Estate SA (ORIA.PA) Income Statement Analysis – Financial Results
- Scandi Standard AB (publ) (0QVR.L) Income Statement Analysis – Financial Results
Narayana Hrudayalaya Limited (NH.NS)
About Narayana Hrudayalaya Limited
Narayana Hrudayalaya Limited provides medical and healthcare services. The company operates and maintains hospitals, clinics, health centers, nursing homes, and other related activities. It offers services in various specialties, including cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. As of June 30, 2022, the company operated through a network of 19 owned/operated hospitals, 2 managed hospitals, 4 heart centers, and 18 clinics and information centers in India, as well as a hospital in the Cayman Islands. It also provides healthcare consultancy services, including licensing of ERP solutions. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50.04B | 45.25B | 37.01B | 25.82B | 31.28B | 28.61B | 22.81B | 18.78B | 16.07B | 13.64B | 10.95B | 8.39B | 6.58B | 4.78B |
| Cost of Revenue | 37.80B | 26.61B | 20.22B | 15.64B | 17.78B | 16.85B | 13.91B | 11.09B | 9.63B | 8.22B | 6.67B | 5.32B | 4.21B | 3.12B |
| Gross Profit | 12.24B | 18.63B | 16.80B | 10.19B | 13.50B | 11.76B | 8.90B | 7.69B | 6.45B | 5.42B | 4.28B | 3.08B | 2.37B | 1.65B |
| Gross Profit Ratio | 24.45% | 41.18% | 45.38% | 39.45% | 43.16% | 41.10% | 39.03% | 40.93% | 40.12% | 39.76% | 39.09% | 36.64% | 36.00% | 34.62% |
| Research & Development | 29.83M | 26.18M | 25.63M | 23.86M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.62B | 1.67B | 1.12B | 1.06B | 1.23B | 1.31B | 983.55M | 832.08M | 673.71M | 657.31M | 537.40M | 366.57M | 249.92M | 200.26M |
| Selling & Marketing | 1.39B | 1.17B | 831.13M | 658.66M | 956.71M | 917.64M | 805.51M | 548.07M | 428.96M | 407.24M | 302.50M | 128.54M | 88.59M | 54.18M |
| SG&A | 3.00B | 2.84B | 1.95B | 1.72B | 2.18B | 2.22B | 1.79B | 1.38B | 1.10B | 1.06B | 839.90M | 495.11M | 338.51M | 254.44M |
| Other Expenses | 105.91M | 654.45M | 68.53M | 74.24M | 86.58M | 91.25M | 107.61M | 79.76M | 78.67M | 59.26M | 34.58M | 18.01M | 19.28M | 16.21M |
| Operating Expenses | 2.19B | 11.08B | 11.75B | 9.97B | 10.93B | 10.07B | 7.61B | 5.93B | 5.26B | 4.56B | 3.49B | 2.70B | 1.90B | 1.40B |
| Cost & Expenses | 40.83B | 37.69B | 31.97B | 25.60B | 28.71B | 26.92B | 21.51B | 17.03B | 14.89B | 12.77B | 10.16B | 8.02B | 6.11B | 4.53B |
| Interest Income | 363.27M | 151.73M | 78.70M | 130.74M | 45.72M | 33.04M | 42.81M | 52.39M | 17.10M | 8.04M | 5.22M | 4.20M | 6.46M | 7.70M |
| Interest Expense | 1.12B | 694.60M | 655.71M | 753.97M | 849.22M | 712.01M | 445.56M | 209.59M | 275.70M | 361.86M | 278.92M | 166.11M | 92.39M | 53.34M |
| Depreciation & Amortization | 2.42B | 2.10B | 1.83B | 1.84B | 1.86B | 1.37B | 999.50M | 799.21M | 752.50M | 666.90M | 574.43M | 460.07M | 372.32M | 321.35M |
| EBITDA | 12.43B | 10.46B | 6.97B | 2.16B | 4.44B | 3.11B | 2.40B | 2.50B | 1.60B | 1.41B | 1.45B | 985.01M | 864.30M | 594.02M |
| EBITDA Ratio | 24.83% | 22.79% | 18.52% | 8.23% | 14.32% | 10.80% | 10.02% | 13.52% | 12.26% | 11.19% | 12.71% | 9.96% | 12.96% | 12.23% |
| Operating Income | 9.42B | 7.67B | 4.81B | 68.65M | 2.48B | 1.62B | 1.30B | 1.76B | 1.19B | 865.66M | 790.35M | 373.36M | 464.26M | 249.41M |
| Operating Income Ratio | 18.83% | 16.96% | 13.00% | 0.27% | 7.93% | 5.68% | 5.69% | 9.35% | 7.38% | 6.35% | 7.22% | 4.45% | 7.06% | 5.22% |
| Total Other Income/Expenses | -534.94M | -7.45B | -636.07M | -709.79M | -953.41M | -753.21M | -493.46M | -403.06M | -685.42M | -572.15M | -223.53M | -35.36M | -77.72M | -41.16M |
| Income Before Tax | 8.89B | 7.52B | 4.30B | -560.67M | 1.61B | 933.95M | 803.66M | 1.35B | 710.83M | 293.51M | 566.82M | 338.00M | 386.54M | 208.25M |
| Income Before Tax Ratio | 17.76% | 16.61% | 11.61% | -2.17% | 5.16% | 3.26% | 3.52% | 7.21% | 4.42% | 2.15% | 5.18% | 4.03% | 5.88% | 4.36% |
| Income Tax Expense | 989.04M | 1.45B | 876.58M | -417.73M | 422.53M | 341.18M | 289.64M | 523.66M | 306.13M | 175.20M | 213.48M | 99.65M | 129.32M | 71.84M |
| Net Income | 7.89B | 6.06B | 3.42B | -143.04M | 1.19B | 591.69M | 513.47M | 830.52M | 191.27M | -108.61M | 317.08M | 247.96M | 257.54M | 136.41M |
| Net Income Ratio | 15.77% | 13.40% | 9.24% | -0.55% | 3.80% | 2.07% | 2.25% | 4.42% | 1.19% | -0.80% | 2.90% | 2.95% | 3.92% | 2.86% |
| EPS | 38.86 | 29.85 | 16.85 | -0.70 | 5.86 | 2.92 | 2.53 | 4.10 | 1.06 | -0.57 | 1.68 | 1.32 | 1.37 | 0.72 |
| EPS Diluted | 38.86 | 29.85 | 16.84 | -0.70 | 5.86 | 2.92 | 2.53 | 4.09 | 1.06 | -0.56 | 1.68 | 1.32 | 1.37 | 0.72 |
| Weighted Avg Shares Out | 203.10M | 203.07M | 202.96M | 202.92M | 202.90M | 202.80M | 202.56M | 202.36M | 200.43M | 190.91M | 204.36M | 204.36M | 204.36M | 204.36M |
| Weighted Avg Shares Out (Dil) | 203.10M | 203.10M | 203.10M | 202.92M | 203.04M | 202.92M | 203.00M | 202.84M | 203.63M | 192.29M | 204.36M | 204.36M | 204.36M | 204.36M |
Source: https://incomestatements.info
Category: Stock Reports